GFAP and Alzheimer disease: In summary, this comparison between Tspo and Gfap highlighted that Gfap exhibits both higher baseline expression and greater upregulation in pathology, making it a promising and potentially superior biomarker for the diagnosis of AD chronic neuroinflammation (Fig 5F).